, Tracking Stock Market Picks
Enter Symbol:
Arthrocare Corporation (ARTC) [hlAlert]

down 50.54 %

Arthrocare Corporation (ARTC) downgraded to Hold by Needham

Posted on: Monday,  Jul 21, 2008  1:25 PM ET by Needham

Needham rated Hold Arthrocare Corporation (NASDAQ: ARTC) on 07/21/2008. Previously Needham rated Strong Buy Arthrocare Corporation (NASDAQ: ARTC) on 05/22/2008.,
when the stock price was $46.93. Since then, Arthrocare Corporation has lost 50.54% as of 07/21/2008's recent price of $23.21.
If you would have followed the previous Needham's recommendation on ARTC, you would have lost 50.54% of your investment in 60 days.

ArthroCare Corp. is a medical device company that develops, manufactures and markets products based on its patented Coblation technology. The company's soft-tissue surgery systems consist of a controller unit and an assortment of disposable devices that are specialized for specific types of surgery. The company's strategy includes applying its patented Coblation technology to a range of soft-tissue surgical markets, including arthroscopic surgery, cosmetic surgery, nose and throat surgery, spinal surgery, neurosurgery, general surgery, and cardiology applications.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/21/2008 1:25 PM Hold
as of 12/24/2008
1 Week up  27.08 %
1 Month down  -25.00 %
3 Months down  -61.92 %
1 YTD up  30.81 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/22/2008 9:25 AM Buy
46.93 80.00
8/13/2007 9:25 AM Buy
51.58 64.00
7/27/2007 9:25 AM Buy
49.22 52.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy